Among patients with high-grade serous ovarian carcinoma, SIK2 was found to be significantly overexpressed in omental metastatic tumors, with the highest SIK2 level observed at the interface between cancer cells and adipocytes, compared with the level in the corresponding primary tumor. This evidence concerns the gene SIK2 and cancer.